HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Barbara Savoldo Selected Research

I-E-antigen

10/2018CD30-Redirected Chimeric Antigen Receptor T Cells Target CD30+ and CD30- Embryonal Carcinoma via Antigen-Dependent and Fas/FasL Interactions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Barbara Savoldo Research Topics

Disease

79Neoplasms (Cancer)
02/2022 - 01/2002
10Hematologic Neoplasms (Hematological Malignancy)
09/2021 - 09/2008
10Neuroblastoma
11/2020 - 11/2008
9Lymphoma (Lymphomas)
11/2021 - 05/2011
8Hodgkin Disease (Hodgkin's Disease)
02/2022 - 10/2007
8Graft vs Host Disease (Graft-Versus-Host Disease)
06/2015 - 08/2009
5Infections
06/2015 - 08/2009
4Multiple Myeloma
03/2019 - 07/2002
4Virus Diseases (Viral Diseases)
04/2014 - 09/2005
4Melanoma (Melanoma, Malignant)
12/2011 - 09/2008
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2021 - 12/2006
3Glioblastoma (Glioblastoma Multiforme)
10/2021 - 01/2018
3Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2015 - 12/2006
3Leukemia
09/2014 - 11/2011
3Testicular Neoplasms (Testicular Cancer)
09/2014 - 09/2008
3Lymphoproliferative Disorders (Lymphoproliferative Disorder)
05/2006 - 01/2002
2Lung Neoplasms (Lung Cancer)
01/2022 - 01/2022
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 11/2013
2Breast Neoplasms (Breast Cancer)
01/2020 - 06/2007
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2019 - 01/2019
2Cytokine Release Syndrome
12/2018 - 06/2015
2B-Cell Lymphoma (Lymphoma, B Cell)
05/2011 - 12/2006
2Inflammation (Inflammations)
01/2010 - 07/2009
1Brain Neoplasms (Brain Tumor)
01/2022
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022
1Retinoblastoma (Glioblastoma, Retinal)
10/2020
1Retinal Neoplasms
10/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Sarcoma (Soft Tissue Sarcoma)
01/2020
1Triple Negative Breast Neoplasms
01/2020
1Adenocarcinoma
11/2019
1Ovarian Neoplasms (Ovarian Cancer)
11/2019
1Embryonal Carcinoma
10/2018
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
10/2018
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
09/2017
1Lymphopenia (Lymphocytopenia)
01/2016
1Exanthema (Rash)
06/2015
1Hyperthermia
06/2015

Drug/Important Bio-Agent (IBA)

48Chimeric Antigen ReceptorsIBA
01/2022 - 06/2007
33AntigensIBA
01/2022 - 07/2002
8CytokinesIBA
11/2021 - 05/2006
8Interleukin-15 (Interleukin 15)IBA
11/2020 - 10/2007
7Interleukin-2 (IL2)IBA
06/2014 - 06/2007
4EpitopesIBA
10/2019 - 12/2011
4Proteins (Proteins, Gene)FDA Link
05/2015 - 09/2009
3Ki-1 AntigenIBA
01/2022 - 06/2009
3fludarabineIBA
11/2020 - 06/2015
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2018 - 06/2015
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2018 - 01/2015
3CD19-specific chimeric antigen receptorIBA
01/2016 - 10/2013
3AutoantigensIBA
01/2015 - 07/2002
3Interleukin-7 (Interleukin 7)IBA
06/2014 - 05/2009
3Antiviral Agents (Antivirals)IBA
10/2013 - 04/2010
2Immunoglobulins (Immunoglobulin)IBA
11/2021 - 12/2006
2InterleukinsIBA
10/2020 - 01/2013
2GD2 gangliosideIBA
10/2020 - 09/2009
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 01/2018
2AntibodiesIBA
01/2019 - 09/2009
2Pharmaceutical PreparationsIBA
01/2018 - 11/2011
2Monoclonal AntibodiesIBA
09/2017 - 06/2007
2CD19 AntigensIBA
01/2017 - 05/2011
2VaccinesIBA
01/2016 - 01/2013
2AP 1903 reagentIBA
06/2015 - 11/2011
2SurvivinIBA
01/2015 - 12/2011
2Biological ProductsIBA
09/2014 - 11/2012
2Viral AntigensIBA
10/2013 - 01/2013
2HLA Antigens (Human Leukocyte Antigens)IBA
12/2011 - 08/2009
2ChemokinesIBA
01/2010 - 06/2009
2Chemokine ReceptorsIBA
01/2010 - 06/2009
1Antineoplastic Agents (Antineoplastics)IBA
01/2022
1Enhancer of Zeste Homolog 2 ProteinIBA
01/2022
1tazemetostatIBA
01/2022
1CCR2 ReceptorsIBA
01/2022
1Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
11/2021
1FibrinIBA
10/2021
1Surface Antigens (Surface Antigen)IBA
01/2021
1HydrogelsIBA
10/2020
1ErbB Receptors (EGF Receptor)IBA
01/2020
1Cetuximab (Erbitux)FDA Link
01/2020
1Panitumumab (Vectibix)FDA Link
01/2020
1Interferon-gamma (Interferon, gamma)IBA
01/2020
1Interleukin-18 (Interleukin 18)IBA
01/2020
1Interleukin-23 (Interleukin 23)IBA
01/2020
1Cancer VaccinesIBA
10/2019
1Programmed Cell Death 1 ReceptorIBA
01/2019
1I-E-antigenIBA
10/2018
1chondroitin sulfate proteoglycan 4IBA
01/2018
1Immune Checkpoint InhibitorsIBA
01/2017
1EnzymesIBA
06/2015
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
06/2015

Therapy/Procedure

26Immunotherapy
02/2022 - 01/2002
26Therapeutics
02/2022 - 06/2005
5Stem Cell Transplantation
11/2011 - 01/2002
3Drug Therapy (Chemotherapy)
12/2019 - 11/2012
3Hematopoietic Stem Cell Transplantation
01/2014 - 08/2009
3Transplantation
01/2014 - 08/2009
3Liver Transplantation
11/2006 - 09/2005
2Cell- and Tissue-Based Therapy (Cell Therapy)
01/2018 - 01/2018
1Intravenous Administration
10/2021
1Injections
10/2020